Demyelinating Disorders

The damage of the protective covering (myelin sheath) that surrounds nerve fibers in brain, optic nerves and spinal cord leads to development of demyelinating disorders. The damaged myelin sheath makes the nerve impulses slow or even stop, causing neurological problems. Demyelination causes neurological deficits, such as vision changes, weakness, altered sensation, and behavioral or cognitive problems. Demyelination can occur at any age.

Symptoms of demyelinating diseases include

Loss of vision
Numbness or tingling of  upper or lower limbs
Weakness of the arms or legs
Poor coordination/gait problem
Trouble walking
Difficulty in swallowing
Slurred speech
Deceased bowel or bladder control
Impaired memory
Mood or behavioral changes
Genetic mutations, infectious agents, autoimmune reactions, Vitamin B12 deficiency and other unknown factors results in dysmyelination.

Sub-track

  • Acute Disseminated Encephalomyelitis
  • Balo’s Disease
  • Charcot-Marie-Tooth Disease
  • Guillain-Barre Syndrome
  • HTLV-I Associated Myelopathy
  • Neuromyelitis Optica
  • Schilder’s Disease
  • Transverse Myelitis
  • Diagnosis and treatment

Market Analysis: The Demyelinating Disorders market is experiencing varied Compound Annual Growth Rates (CAGRs) from 2025 to 2030, depending on the specific condition and market analysis. Projections for the overall Demyelinating Diseases Therapeutics Market range from 6.3% (2025-2034) to 10.7% (2024-2030). More specifically, the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market is expected to grow between 5.83% (reaching $3.50 billion by 2030 from $2.64 billion in 2025) and 7.50% (2025-2032). Furthermore, the Hereditary Central Nervous System Demyelinating Diseases Market is forecasted to see a 9.71% CAGR from 2025 to 2035. Keep in mind that these figures come from different market reports and may use varying methodologies, so always consult original sources for complete details.

ALSO READ Neurology Neurosurgery Neuroscience Neuropsychiatry Pain Disorder and Management Central Nervous System Pediatric Neurology Neuro-Oncology and Brain Tumors Neurophysiology Neuroimmunology Neuropathology Neuroimaging Neurodegenerative disease and Neurodegeneration Neurological Disorders Sleep Disorder Stroke Movement Disorders Parkinsons Disease Epilepsy Multiple Sclerosis Alzheimers Disease and Dementia Neuromuscular Disease Case Studies and Clinical Trials Novel Treatment Strategies Speech Disorders Demyelinating Disorders Cerebrovascular Disorders Autoimmune and Inflammatory Disorders Neuropathy Headache and Facial Pain Diagnosis and Screening of Neurological Disorders Neuropharmacology and Neurochemistry Stem Cells and Neuroregeneration Cognitive Neuroscience Motor System Disorders Behavioral Neurology Computational Neuroscience Neurogenetics Spinal Neurosurgery Pediatric Neurosurgery Stereotactic and Functional Neurosurgery Neurovascular Surgery Intraoperative Neurophysiology Peripheral Nerve Surgery Robotics in Neurosurgery Latest advancement in Brain Surgery Skull Base Surgery Trauma and Critical Care Child Psychology Social Cognitive Neuroscience Neurophysics Neuroradiology Neurorobotics Advanced Imaging Techniques Personalized Medicine Neuroinformatics Gene Therapy Neural Interface and Brain-Computer Interface BCI Neurorehabilitation Regenerative Medicine and Stem Cell Therapy Telemedicine in Neurology Nano-Neuroscience Neurosurgical Innovations Neuroethics Precision Psychiatry Neuromodulation and New Therapeutic Approaches Microbiome and Neurological Health Neurological Implications of COVID-19

Tags
Neurology Conferences 2026 USA Neurology Conferences 2027 UK Brain Cancer Conferences Peers Alley Child Psychology Conferences Psychiatry Conferences 2027 Neurological Disorders Conferences Epilepsy Conferences Seizures Conferences Cerebrovascular Disease Conferences Spinal Disorders Conferences Muscular Dystrophy Conferences Neuroscience Conferences 2026 Dubai Peers Alley Media Canada Neurology Conferences Europe

+1 (506) 909-0537